[Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins]
- PMID: 17502294
[Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins]
Abstract
Hepatitis C virus (HCV) is an enveloped virus and encodes two envelope glycoproteins, E1 and E2. E1 and E2 are transmembrane type I proteins with a N-terminal ectodomain and C-terminal anchor. During their synthesis, E1 and E2 ectodomains are targeted in the endoplasmic reticulum lumen where they are modified by N-linked glycosylation. After their synthesis, E1 and E2 assemble as a non-covalent heterodimer. The N-linked glycosylation is based on the recognition of specific asparagine residue in the context of the consensus sequence Asn-X-Ser/Thr. E1 contains potentially 4 or 5 N-linked glycosylation sites and E2 up to 11. Recent data indicated that some glycans of glycoproteins E1 and E2 play a major role in protein folding and heterodimer formation. Some N-linked glycans of E2 were involved in interactions with CD81, a putative cellular receptor for HCV. It appeared that N-linked glycans of E1 and E2 played an important role of in the viral entry.
Similar articles
-
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.J Virol. 2005 Jul;79(13):8400-9. doi: 10.1128/JVI.79.13.8400-8409.2005. J Virol. 2005. PMID: 15956584 Free PMC article.
-
Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.Virology. 2004 Jul 1;324(2):273-85. doi: 10.1016/j.virol.2004.03.039. Virology. 2004. PMID: 15207615
-
Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.Virology. 1997 Apr 28;231(1):119-29. doi: 10.1006/viro.1997.8516. Virology. 1997. PMID: 9143310
-
Topology of hepatitis C virus envelope glycoproteins.Rev Med Virol. 2003 Jul-Aug;13(4):233-41. doi: 10.1002/rmv.391. Rev Med Virol. 2003. PMID: 12820185 Review.
-
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.Front Immunol. 2018 Apr 27;9:910. doi: 10.3389/fimmu.2018.00910. eCollection 2018. Front Immunol. 2018. PMID: 29755477 Free PMC article. Review.
Cited by
-
Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens.Biotechnol Adv. 2024 Jan-Feb;70:108283. doi: 10.1016/j.biotechadv.2023.108283. Epub 2023 Nov 14. Biotechnol Adv. 2024. PMID: 37972669 Free PMC article. Review.
-
Comprehensive N-glycosylation profiling of recombinant spike S1 protein from the wild-type SARS-CoV-2 and its variants.Front Immunol. 2025 Jul 16;16:1592142. doi: 10.3389/fimmu.2025.1592142. eCollection 2025. Front Immunol. 2025. PMID: 40755778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources